Inside the research
Envista Holdings Corporation
NVST Research profile · latest available data
Price overview
$23.95
▼ -0.12 (-0.5%)
| 52w hi | $30.26 |
|---|---|
| 52w lo | $18.95 |
| Vol | 3.25M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.06
| Short | -0.36 |
|---|---|
| Medium | +0.07 |
| Long | +0.29 |
computed 2026-09-27
Key fundamentals
Envista Holdings Corporation
Healthcare · Medical Instruments & Supplies
| Market cap | $3.85B |
|---|---|
| Enterprise value | $4.31B |
| Trailing P/E | 41.29x |
| Forward P/E | 14.37x |
| EV / EBITDA | 10.61x |
| P / S (ttm) | 1.35x |
| Profit margin | 3.3% |
| Return on equity | 3.1% |
| Revenue growth | +7.1% |
| Earnings growth | +111.3% |
| Debt / equity | 51.62 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.28 | |
| Sector | +0.08 | |
| Technical | -0.14 | |
| Earnings | +0.00 | |
| Sentiment | -0.14 |
macro × 1.00 · 2026-09-27
Business overview
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Risk Metrics
| Beta vs SPX | 1.22 |
|---|---|
| Corr SPX | 0.49 |
| Annual vol | 39.8% |
| Annual ret | +19.4% |
| Sharpe | 0.49 |
| Max DD | -33.9% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-05 | Earnings Release, Reg FD Disclosure… | read |
| 2026-06-03 | Officer / Director Change, Exhibits | read |
| 2026-05-21 | Shareholder Vote, Exhibits | read |
| 2026-05-06 | Earnings Release, Reg FD Disclosure… | read |
| 2026-02-05 | Earnings Release, Reg FD Disclosure… | read |
| 2025-10-29 | Earnings Release, Reg FD Disclosure… | read |
| 2025-10-29 | Reg FD Disclosure, Exhibits | read |
| 2025-09-17 | Officer / Director Change, Exhibits | read |
| 2025-07-31 | Earnings Release, Reg FD Disclosure… | read |
| 2025-07-16 | Officer / Director Change, Exhibits | read |
| 2025-06-12 | Shareholder Vote, Exhibits | read |
| 2025-05-01 | Earnings Release, Reg FD Disclosure… | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-25 | Keel Paul A | Chief Executive Officer | Withheld for tax | 12.81K | $300.16K |
| 2026-05-19 | Carruthers Wendy | Grant | 9.33K | — | |
| 2026-05-19 | TSINGOS CHRISTINE A | Grant | 9.33K | — | |
| 2026-05-19 | Jain Vivek | Grant | 9.33K | — | |
| 2026-05-19 | GALLAHUE KIERAN | Grant | 9.33K | — | |
| 2026-05-19 | Pierce James Andrew | Grant | 9.33K | — | |
| 2026-05-19 | Raskas Daniel | Grant | 9.33K | — | |
| 2026-05-19 | Huennekens R Scott | Grant | 12.59K | — | |
| 2026-02-25 | Hammes Eric D. | Chief Financial Officer | Withheld for tax | 2.04K | $60.51K |
| 2026-02-25 | Hammes Eric D. | Chief Financial Officer | Grant | 16.05K | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 10 |
| Top-5 share | 93.9% |
| HHI | 2,687 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| AQR Capital Management | $106.02M | 4.02M |
| Renaissance Technologies | $40.07M | 1.52M |
| Fidelity / FMR LLC | $34.57M | 1.31M |
| Millennium Management | $30.22M | 1.15M |
| State Street Corp | $12.71M | 12.68M |
| Norges Bank (Norway sovereign) | $9.82M | 372.50K |
| Citadel Advisors | $3.50M | 132.94K |
| Bridgewater Associates | $1.10M | 41.65K |
| Capital Research / Capital World | $32.02K | 32.00K |
| T. Rowe Price Group | $4.60K | 174.41K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2019–2025 · 7 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.72B | +26.2% | |
| Gross profit | $1.44B | +22.6% | |
| Operating income | -$1.04B | -35.3% | |
| Net income | -$1.12B | +2.2% | |
| Cash from ops | $336.50M | -1.1% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $24.02 | $24.19 | $23.77 | $23.95 | 3.25M |
| Sep 24 | $23.80 | $24.13 | $23.60 | $24.07 | 2.54M |
| Sep 23 | $24.12 | $24.39 | $23.81 | $23.82 | 2.41M |
| Sep 22 | $23.82 | $24.48 | $23.56 | $24.18 | 4.04M |
| Sep 21 | $23.68 | $23.68 | $23.21 | $23.43 | 3.54M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →